Chadds Ford, PA – According to filings with the U.S. Securities and Exchange Commission, Mobilion Systems is raising $6,000,000.00 in new funding. Sources indicate as part of senior management Chief Executive Officer, Melissa Sherman played a key role in securing the recent investment and it will aid in aggressively expanding the company, as well as broaden and accelerate product development.

About Mobilion Systems

Mobilion’s technology makes it easy to separate, identify and analyze the most challenging molecules that other instruments fail to detect. Our higher resolution, faster analysis and simpler workflows reveal molecules that are most important in characterizing biologic therapeutics, discovering biomarkers, and improving the accuracy of diagnostic tests.  We make today’s treatment’s safer and more effective, empower tomorrow’s disease prediction and diagnosis, and accelerate the development of new therapies.

To learn more about Mobilion Systems, visit http://mobilionsystems.com/

Contact:
Melissa Sherman, Chief Executive Officer
484-246-6060
melissa.sherman@mobilionsystems.com
https://www.linkedin.com/in/melissa-sherman-ph-d-4711004/

SOURCE: http://www.intelligence360.io
Copyright (c) 2020 SI360 Inc. All rights reserved